Showing posts with label Heartbeats of Sterilization. Show all posts
Showing posts with label Heartbeats of Sterilization. Show all posts

Friday, 30 January 2015

Significance of D-value for establishing hold time for TS-products

Sterilization is key to keeping products, items, articles free of known contamination. One could choose different modes of sterilization such as moist heat, dry heat, ethylene oxide, gamma irradiation, filtration etc. The use of moist heat is the most preferred method in the pharmaceutical manufacturing domains.
Terminal Sterilization (TS) is the process that involves moist heat sterilization of filled and sealed products like vials, ampoules, bottles, bags etc. The sterile hold duration setting for TS products is one of the most critical tasks in the process.  Container size and the fill volume are the key attributes to be considered. A D-value determination (define D-value) helps in the fixing the sterile hold duration of the products. Sufficient care must be built into the design of the experiments to ensure that increase or decrease in the hold time does not affect the quality attributes of the terminally sterilized product.
During the design and development of TS-cycle where the customer had qualified the cycle by coupling a physical and biological approach, evaluating the product attributes post the heat exposure phase depicted an increased impurity level. An investigation of this problem revealed two aspects,
1.      Cycle designed was based on an over-kill approach
2.      D-value used was 2.5 minutes
We brought the VieNnI’s sterilization expertise and experience to the table. Our work and analysis quickly addressed the situation and the solution was framed.
1.      We suggested that an over-kill approach was the least suitable for TS products.
2.      We brought clarity to the process with explanations of the theory and practice of TS.
3.      D-value determination of the TS-product was performed subsequently which was to the customer’s satisfaction.
4.      Regulatory compliance was ensured. Adequate justification, to revise the process including the cycle and validation, development time and cost was made and checked.
We successfully helped the team in meeting quality acceptance criteria of the product and its specifications.

If your sterilization process needs help, if your validation team needs clarity, and if you want your manufacturing operations to be unhindered by these issues, experts from Vienni are just a call away at 91 80 23506562 or email us at vienni.india@gmail.com. Let us design and develop sterilization process and related solutions for you.

Monday, 29 September 2014

We have a keen “EYE” for API’s to be used in Ophthalmic Formulations!

DHS-Cycle design and development using different Biological Indicators

APIs used in the pharmaceutical industry are generally non-sterile. It is however essential to use sterile APIs to manufacture a sterile product.

An ophthalmic parenteral manufacturer intended to use a dry powdered steroidal API in the formulation of a sterile product. This steroidal API had a bio-burden of 100 CFU/gm. Options considered although were plenty, we had to narrow our choice to a sterilization process in a DHS. Heat exposure studies at the labs depicted that temperatures < 115⁰C was safe, while there was a risk of product degradation at temperatures >115⁰C.

Our study began in earnest to design a sterilization cycle with trials, to achieve the desired results. A series of trials and constant monitoring of the temperature profile helped us determine a matrix of parameters for sterilization. Trials were conducted using Bacillus atrophaeus as a biological indicator. The exposed BIs were subjected to microbiological evaluation where maximum of a 3-Log reduction was recorded. The sterility test trials were clearly found to be meeting specification, however the minimum Sterility Assurance Level expected for the process was  6 log  !

Sticky situation indeed! The trials although were meeting the sterility test specs in flying colours yet were falling short of the expectations when it came to log reduction. A thorough investigation of the process and the testing strategy was undertaken. An elaborate analysis and an organised ‘detective ‘work led us to the issue! A repeat of the study subsequent to problem identification provided results, those that were amazing yet expected a 6-log reduction finally! Two more trials were conducted to confirm the physical parameters and microbiological tests and the results were bang on!

A happy customer, a robust process, great experiments and yet another feather in our cap. If your process needs similar intervention, our technical spirits aren't doused yet and we await your ‘call’ to get nose-deep into tricky situations.

Reach us to reach you at 080-23506562 or write to us at vienni.india@gmail.com 

Wednesday, 3 September 2014

Regulatory and Business impact of Equilibration Time (ET)

Sometime back a sterile manufacturing firm was audited and the regulators found deviations in the ET standard limits for different loads.
All of us are aware that ET is the “period which elapses between the attainment of the sterilization temperature at the reference measuring point and the attainment of the sterilization temperature at all points within the sterilization load” EN ISO 17665-1:2006.


It was very important for the firm to meet the ET standard limits to make sure the following were achieved-


To achieve the same the firm decided to replace the autoclave that was 7-years old as a corrective step subsequent to an internal meeting.
While the team started discussing with autoclave suppliers and manufacturers they faced the dilemma of tackling challenges with changes and alteration.

Seeking alternates to replacements team VienniTM undertook a gap audit, gap assessment and analysis and provided solutions for optimization with revised cycle parameter yielding firm phenomenal savings of a variety.

Team VienniTM took 4 working days to execute this project, ranging from helping the firm to optimize resources which was a permanent solution.
Three successful validation runs were conducted and all met the acceptance criteria for critical parameters including ET.
Now, the firm continues to successfully manufacture the batches without any regulatory hurdle of Equilibration Time. 

Saturday, 19 July 2014

Dry Heat Sterilization Cycle Design & Development at lower temperature


There are standards and references available for people wanting to establish dry heat sterilization cycles at lower temperature. While these standards help in learning, it is indeed a challenge when you are asked to establish dry-heat sterilization process for steroidal API.
This is the story of a project of VIENNI™. The project started like others with initial trials conducted by the client’s in-house validation team. The results were not satisfactory. The challenge persisted while a few facts were overlooked. The product, process and procedures needed an expert’s touch!
The basic challenges:

1.   Product safety and efficacy has to be retained
2.  Development of an effective sterilization cycle recipe
3. Presentation of microbiological results

Vienni was brought-in to support for design and to develop the dry-heat sterilization cycle. The initial gap analysis revealed some interesting facts in the sterilization cycle design process. The most important gaps identified were taken stock of and assessed through discussions. Some of them are as listed below:

      1. Arrangement pattern of containers used to keep load item (The API)
            2.  Use of non-uniform perforated containers
      3.   Location of the containers
      4.  Packing of the load item (the API)
      5.  Cycle parameter establishment
      6.   Product stability at the stated temperature
      7. Temperature profile

The above gaps were systematically addressed and closed. The new process and parameters determined were implemented.
The very first step in the implementation was to address the arrangement pattern of containers, uniform perforated containers, arrangement and location of the containers, optimized packing of the load item, hence, first four challenges were overcome! The next step was to set the physical parameters of the cycle. These parameters were found to be inconsistent and performing above the limit, during initial trials and were identified to be a recurring problem. The Eureka-moment was when the temperature in the load items was reduced to below the temperature recorded during initial trials and the set parameters were revised accordingly. Finally, after a few science-and data-based trials, the temperature inside the product was recorded within the limits.

The last challenge was to prove acceptance through the microbiological studies i.e. BI-incubation and the sterility test. The results of the microbiological studies results were also found as per the pre-determined specifications. A trial run was conducted to evaluate and establish the come-up time, which was found to be insufficient after which some more trials were required to determine the optimum come up time, sterile hold and cool down time. The runs passed the sterility test and the incubation test in flying colours.
The exposure time and temperature of the cycle was set based on the D-value calculation of the biological indicator.

Experience, expertise, rigor and patience helped us establish, develop and design a dry-heat sterilization cycle in a record time. Yet another feather in our cap!